Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes

J Antimicrob Chemother. 1997 Aug;40(2):275-7. doi: 10.1093/jac/40.2.275.

Abstract

We have tested the ability of Streptococcus pyogenes to produce streptococcal pyrogenic exotoxin A (SPEA) and superantigenic activity in the presence of sub-inhibitory concentrations of ampicillin and clindamycin. After 6 h of culture, SPEA production by S. pyogenes was higher in broths containing ampicillin (715.7 +/- 296.4 pg/10(6) cfu) than in broths containing clindamycin (167.1 +/- 31.9 pg/10(6) cfu), a difference that was not significant (P = 0.25). Promitogenic activity of bacterial supernatants was also greater in ampicillin-treated cultures (467.5 +/- 17.2 ccpm/10(6) cfu) than in clindamycin-treated cultures (169.2 +/- 8.9 ccpm/10(6) cfu), a difference that was highly significant (P = 0.0001). The data support the use of clindamycin in the treatment of streptococcal toxic shock-like syndrome, in order to inhibit superantigen synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ampicillin / pharmacology*
  • Anti-Bacterial Agents / pharmacology*
  • Antigens, Bacterial / drug effects*
  • Antigens, Bacterial / metabolism
  • Bacterial Proteins*
  • Clindamycin / pharmacology*
  • Enzyme-Linked Immunosorbent Assay
  • Exotoxins / metabolism*
  • Membrane Proteins*
  • Penicillins / pharmacology*
  • Pyrogens / metabolism*
  • Streptococcus pyogenes / drug effects*
  • Streptococcus pyogenes / immunology
  • Streptococcus pyogenes / metabolism
  • Superantigens / drug effects
  • Superantigens / metabolism

Substances

  • Anti-Bacterial Agents
  • Antigens, Bacterial
  • Bacterial Proteins
  • Exotoxins
  • Membrane Proteins
  • Penicillins
  • Pyrogens
  • SpeA protein, Streptococcus pyogenes
  • Superantigens
  • erythrogenic toxin
  • Clindamycin
  • Ampicillin